Intrinsic Value of S&P & Nasdaq Contact Us

P3 Health Partners Inc. PIII NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
35/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.50
+406.1%

P3 Health Partners Inc. (PIII) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $2.47. It has a SharesGrow Score of 35/100, indicating a weak investment profile with 2 out of 7 criteria passed.

Analyst consensus target is PIII = $13 (+406.1% upside).

Valuation: PIII trades at a trailing Price-to-Earnings (P/E) of -0.1 (S&P 500 average ~25).

Financials: revenue is $1.5B, +12.1%/yr average growth. Net income is $148M (loss), growing at -21.8%/yr. Net profit margin is -10.1% (negative). Gross margin is -9.9% (-0.8 pp trend).

Balance sheet: total debt is $287M with negative equity of -$155M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.24 (tight liquidity). Debt-to-assets is 43.8%. Total assets: $657M.

Analyst outlook: 2 / 4 analysts rate PIII as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 23/100 (Fail), Future 64/100 (Pass), Income 10/100 (Fail).

$12.50
▲ 406.07% Upside
Average Price Target
The 12-month price target for P3 Health Partners Inc. is $12.50.

PIII SharesGrow Score Overview

49/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 23/100
Gross margin is + market cap
FUTURE 64/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range1.52-11.3
Volume44.29K
Avg Volume (30D)89.73K
Market Cap$8.07M
Beta (1Y)0.56
Share Statistics
EPS (TTM)-45.26
Shares Outstanding$3.27M
IPO Date2021-04-06
Employees360
CEOAmir Bacchus
Financial Highlights & Ratios
Revenue (TTM)$1.46B
Gross Profit$-144.32M
EBITDA$-186.14M
Net Income$-147.95M
Operating Income$-270.3M
Total Cash$25.01M
Total Debt$287.29M
Net Debt$262.27M
Total Assets$656.64M
Price / Earnings (P/E)-0.1
Price / Sales (P/S)0.01
Analyst Forecast
1Y Price Target$12.50
Target High$12.50
Target Low$12.50
Upside+406.1%
Rating ConsensusBuy
Analysts Covering4
Buy 50% Hold 50% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS7444132044

Price Chart

PIII
P3 Health Partners Inc.  ·  NASDAQ Capital Marke
Healthcare • Medical - Care Facilities
1.52 52WK RANGE 11.30
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message